483.12
Intuitive Surgical Inc stock is traded at $483.12, with a volume of 2.98M.
It is up +0.42% in the last 24 hours and down -10.20% over the past month.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$481.09
Open:
$475.46
24h Volume:
2.98M
Relative Volume:
1.76
Market Cap:
$173.19B
Revenue:
$9.15B
Net Income/Loss:
$2.61B
P/E Ratio:
67.38
EPS:
7.17
Net Cash Flow:
$1.99B
1W Performance:
-2.57%
1M Performance:
-10.20%
6M Performance:
-15.52%
1Y Performance:
+7.14%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ISRG
Intuitive Surgical Inc
|
483.12 | 172.46B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
176.37 | 51.09B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.87 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
279.20 | 39.87B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
239.26 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
Jul-10-24 | Reiterated | Citigroup | Buy |
May-30-24 | Initiated | Goldman | Buy |
Nov-17-23 | Initiated | HSBC Securities | Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Apr-19-23 | Reiterated | BTIG Research | Buy |
Apr-19-23 | Reiterated | BofA Securities | Buy |
Apr-19-23 | Reiterated | Citigroup | Buy |
Apr-19-23 | Reiterated | Evercore ISI | In-line |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
Apr-19-23 | Reiterated | Raymond James | Outperform |
Apr-19-23 | Reiterated | Stifel | Buy |
Apr-19-23 | Reiterated | Truist | Buy |
Apr-19-23 | Reiterated | Wells Fargo | Overweight |
Mar-29-23 | Initiated | UBS | Neutral |
Mar-23-23 | Initiated | William Blair | Outperform |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-13-22 | Initiated | Mizuho | Neutral |
Oct-12-22 | Initiated | Jefferies | Hold |
Apr-13-22 | Initiated | Truist | Buy |
Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-02-22 | Upgrade | UBS | Neutral → Buy |
Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
Jan-21-22 | Reiterated | BTIG Research | Buy |
Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Evercore ISI | In-line |
Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
Jan-21-22 | Reiterated | Piper Sandler | Neutral |
Jan-21-22 | Reiterated | Raymond James | Outperform |
Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Reiterated | UBS | Neutral |
Jan-21-22 | Reiterated | Wells Fargo | Overweight |
Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
Jul-21-21 | Reiterated | BofA Securities | Neutral |
Jul-21-21 | Reiterated | Citigroup | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
Jul-21-21 | Reiterated | Piper Sandler | Neutral |
Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
Jul-21-21 | Reiterated | Stifel | Buy |
Jul-21-21 | Reiterated | UBS | Neutral |
Jul-21-21 | Reiterated | Wells Fargo | Overweight |
Jul-14-21 | Reiterated | Goldman | Buy |
Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Apr-01-21 | Initiated | Citigroup | Buy |
Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Sep-28-20 | Initiated | Argus | Buy |
Sep-11-20 | Initiated | Wolfe Research | Outperform |
Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
Sep-02-20 | Initiated | Robert W. Baird | Neutral |
Jul-20-20 | Reiterated | Bernstein | Outperform |
Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-17-20 | Downgrade | CFRA | Hold → Sell |
Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-12-19 | Reiterated | Wells Fargo | Outperform |
Nov-21-19 | Initiated | Oppenheimer | Perform |
Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
Apr-02-19 | Initiated | Deutsche Bank | Buy |
Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
When is Intuitive Surgical Inc. stock expected to show significant growthEntry Signal Planner To Watch Now - jammulinksnews.com
Intuitive Surgical’s New Study: A Closer Look at the Ion Endoluminal System - TipRanks
Intuitive Surgical, Inc. (ISRG) Installs 395 da Vinci Systems in Q2, Forecasts 17% Procedure Growth - Insider Monkey
United States Surgical Robots Market Competition, Forecast - GlobeNewswire
United States Surgical Robots Market Competition, Forecast & Opportunities Report 2025-2030, with Medtronic, Intuitive Surgical, Stryker, Medrobotics, TransEnterix, Think Surgical, Accuray, and More - Yahoo Finance
Stock Analysis | Intuitive Surgical OutlookMixed Signals Amid Earnings Volatility - AInvest
Intuitive’s da Vinci 5 surgical system receives CE mark approval - Home | Digital Health
Intuitive Surgical's $1.26B Volume Spike Propels It to 97th Rank Amid Clinical Trial Updates and Market Momentum Plays - AInvest
Should I hold or sell Intuitive Surgical Inc. stock in 2025Expert Picks Signals To Watch Now - jammulinksnews.com
Robotic Surgery Co.'s Antitrust Appeal Backed At 9th Circ. - Law360
How volatile is Intuitive Surgical Inc. stock compared to the marketBreakout Stocks Signals Backed By Experts - jammulinksnews.com
LivsMed Debuts New Robotic System With Telesurgery Capabilities - Medical Product Outsourcing
What makes Intuitive Surgical Inc. stock price move sharplyAdvanced Screener Ideas For Every Investor - jammulinksnews.com
Intuitive Surgical (ISRG) Soared on Solid Financial Results - Insider Monkey
North America Microsurgery Robot Market Size & Growth, 2033 - Market Data Forecast
Intuitive Surgical Ranks 115th in $880M Trading Volume as Robotic Growth and Patent Approval Drive Short-Term Gains - AInvest
Intuitive Surgical, Inc. (ISRG): “I Really Like” It, Says Jim Cramer - MSN
Lung Cancer Surgery Market to Reach USD 2.64 Billion by 2035, - openPR.com
Cathie Wood Goes Shopping: 3 Stocks She Just Bought - The Motley Fool
Jim Cramer on Intuitive Surgical: “I’m Inclined to Recommend the Stock” - Insider Monkey
5 Must-Read Analyst Questions From Intuitive Surgical’s Q2 Earnings Call - Yahoo Finance
Jim Cramer on Intuitive Surgical: "I’m Inclined to Recommend the Stock" - Yahoo Finance
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds By Investing.com - Investing.com South Africa
One Buy-Rated Stock With An Unbreakable Moat That You Can’t Ignore - Barchart.com
HRH heralds arrival of robotic-assisted surgery - The Daily World
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
ISRG's Gross Margin Falls on Product Transition and Trade Pressures - Yahoo Finance
What are Intuitive Surgical Inc. company’s key revenue driversOutstanding capital appreciation - jammulinksnews.com
Intuitive Surgical's Insider Selling: A Signal or a Strategy in a Robotic Surge? - AInvest
Intuitive surgical gains momentum from procedure growth - MarketScreener
How strong is Intuitive Surgical Inc. company’s balance sheetAccess powerful market insights for free - jammulinksnews.com
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2025 Earnings Call Transcript - MSN
Intuitive Surgical (ISRG) Shares Dip Despite Strong Q2 Performan - GuruFocus
12 out of 12 healthcare firms top revenue estimates this week: Earnings Scorecard - Seeking Alpha
Intuitive Surgical’s Strong Performance and Growth Potential Reinforce Buy Rating - TipRanks
Intuitve surgical EVP Curet sells $2.2m in shares - Investing.com
Where Will Intuitive Surgical Be in 5 Years? - MSN
Daily Turnover | The turnover of Intuitive Surgical on 7/25 was $925.50 Million, Ranking 87 - AInvest
What drives Intuitive Surgical Inc. stock priceUnmatched market gains - PrintWeekIndia
ISRG Q2 Deep Dive: New Platform Drives Procedure Growth Amid Global Expansion - Yahoo Finance
Intuitive Surgical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Intuitive Surgical updates 2025 da Vinci procedure growth guidance to 15.5%-17% as da Vinci 5 launches expand - MSN
Intuitive Surgical’s Earnings Call: Growth Amid Challenges - The Globe and Mail
Intuitive Surgical Inc. Plummets to 70th in Trading Volume Despite Strong Financials and Strategic Partnerships - AInvest
What risks could impact Intuitive Surgical Inc. stock performanceOver 200% growth - jammulinksnews.com
FTC May Join Intuitive Surgical Antitrust Appeal - Law360
Senior DOJ Antitrust Officials Placed on Leave Amid Internal Turmoil - PYMNTS.com
Intuitive Surgical Crushes Q2 Expectations, So Why No Rally? - MSN
Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Intuitive Surgical Sees Early Wins With Da Vinci 5, Lifts FY25 Guidance As Tariff Impact Eases - insights.citeline.com
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Intuitive Surgical Inc Stock (ISRG) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
498.64 |
7,893 |
3,935,756 |
13,187 |
GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
495.24 |
2,800 |
1,386,663 |
18,520 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):